By targeting plasmacytoid DCs and the IFNα/CX3CL1/CX3CR1 pathway, it may be possible to inhibit HCC recurrence induced by surgical stress, thereby reducing postoperative immunosuppression [162]. Here, CX3CL1 is linked to hepatocellular carcinoma.